Quinten Health will announce in the coming months strategic partnerships with big pharma companies and data owners to launch the first disease modeling platforms.
These moves are designed to strengthen the company’s medical and scientific focus and support its continued record growth through closer alignment of all aspects of strategy, sales, and delivery to delight customers
Cytel has now established entities in Australia, Shanghai, Beijing, and Singapore, and plans to expand into Seoul and Tokyo in the coming years.
The acquisition reaffirms Infosys’ commitment to help global life sciences companies
The Centre aims at promoting innovation among the scientific community to improve healthcare solutions around the globe
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
This multicenter, open-label Phase I study is designed to assess the safety and tolerability
Dr. Rizo brings extensive industry leadership experience to Vividion, having held multiple senior executive roles during her career at both biotechnology and large pharmaceutical companies.
Subscribe To Our Newsletter & Stay Updated
